Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR1 and PAR4 in platelets

被引:38
|
作者
Navarro-Nunez, L. [1 ]
Rivera, J. [1 ]
Guerrero, J. A. [1 ]
Martinez, C. [1 ]
Vicente, V. [1 ]
Lozano, M. L. [1 ]
机构
[1] Univ Murcia, Unit Haematol & Med Oncol, Ctr Reg Hemodonac, Murcia 30003, Spain
关键词
flavonoids; thrombin; protease-activated receptors; platelets; TYROSINE KINASE INHIBITOR; THROMBOXANE A(2); P2Y(12) RECEPTOR; FLAVONOIDS INHIBIT; CA2+ MOBILIZATION; GAMMA-THROMBIN; HEART-DISEASE; CALDAG-GEFI; AGGREGATION; SECRETION;
D O I
10.1111/j.1476-5381.2009.00440.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: The modulation by flavonoids of platelet responses induced by thrombin has been little investigated, and the antiplatelet activity, as well as possible inhibitory mechanisms of these compounds on thrombin signalling, has not yet been elucidated. We explored whether flavonoids affect platelet signalling pathways triggered by thrombin and by the selective activation of its protease-activated receptors (PARs) 1 and 4, and analysed the antagonism of these polyphenols at thrombin receptors. Experimental approach: We investigated the effect of a range of polyphenolic compounds on platelet aggregation, 5-HT secretion, intracellular calcium mobilization, protein kinase activity and tyrosine phosphorylation, triggered by thrombin and PAR agonist peptides (PAR-APs). The ability of these flavonoids to bind to thrombin receptors was investigated by competitive radioligand binding assays using 125I-thrombin. Key results: Quercetin, apigenin and genistein impaired platelet aggregation, as well as 5-HT release and calcium mobilization, induced by thrombin and PAR-APs. Quercetin and apigenin were inhibitors of protein kinases, but genistein exhibited a minimal ability to suppress platelet phosphorylation. Binding assays did not establish any kind of interaction between thrombin receptors and any of the flavonoids tested. Conclusions and implications: Quercetin, apigenin and genistein did not inhibit thrombin responses by interacting with thrombin receptors, but by interfering with intracellular signalling. While inhibition by genistein may be a consequence of affecting calcium mobilization, subsequent platelet secretion and aggregation, for quercetin and apigenin, inhibition of kinase activation may also be involved in the impairment of platelet responses.
引用
收藏
页码:1548 / 1556
页数:9
相关论文
共 50 条
  • [1] Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets
    Falker, Knut
    Haglund, Linda
    Gunnarsson, Peter
    Nylander, Martina
    Lindahl, Tomas L.
    Grenegard, Magnus
    BIOCHEMICAL JOURNAL, 2011, 436 : 469 - 480
  • [2] Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets
    Duvernay, Matthew T.
    Temple, Kayla J.
    Maeng, Jae G.
    Blobaum, Anna L.
    Stauffer, Shaun R.
    Lindsley, Craig W.
    Hamm, Heidi E.
    MOLECULAR PHARMACOLOGY, 2017, 91 (01) : 39 - 47
  • [3] Protease-activated Receptor 1 (PAR1) and PAR4 Heterodimers Are Required for PAR1-enhanced Cleavage of PAR4 by α-Thrombin
    Arachiche, Amal
    Mumaw, Michele M.
    de la Fuente, Maria
    Nieman, Marvin T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (45) : 32553 - 32562
  • [4] Complement factor C4a does not activate protease-activated receptor 1 (PAR1) or PAR4 on human platelets
    Han, Xu
    de la Fuente, Maria
    Nieman, Marvin T.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (01) : 104 - 110
  • [5] Agonists of protease-activated receptors (PAR1, PAR2 and PAR4) do not appear to be mediators of NANC contractions in rat bladder
    Long, JM
    Kaefer, M
    Packer, CS
    FASEB JOURNAL, 2004, 18 (05): : A1083 - A1083
  • [6] Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter
    Huang, Shih-Che
    REGULATORY PEPTIDES, 2007, 142 (1-2) : 37 - 43
  • [7] Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets
    Covic, L
    Gresser, AL
    Kuliopulos, A
    BIOCHEMISTRY, 2000, 39 (18) : 5458 - 5467
  • [8] Protease-activated receptors: PAR4 and counting: how long is the course?
    Hollenberg, MD
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (07) : 271 - 273
  • [9] Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.
    Covic, L
    Gresser, AL
    Kuliopulos, A
    FASEB JOURNAL, 2000, 14 (08): : A1347 - A1347
  • [10] Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions
    Bilodeau, Matthew L.
    Hamm, Heidi E.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 322 (02): : 778 - 788